Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
UBS
Express Scripts
Fuji
Fish and Richardson
Teva
Julphar
Medtronic
Merck

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202099

« Back to Dashboard

NDA 202099 describes ZENATANE, which is a drug marketed by Dr Reddys Labs Ltd and is included in one NDA. It is available from one supplier. Additional details are available on the ZENATANE profile page.

The generic ingredient in ZENATANE is isotretinoin. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the isotretinoin profile page.
Summary for 202099
Tradename:ZENATANE
Applicant:Dr Reddys Labs Ltd
Ingredient:isotretinoin
Patents:0
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 202099
Ingredient-typeRetinoids
Medical Subject Heading (MeSH) Categories for 202099
Suppliers and Packaging for NDA: 202099
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZENATANE isotretinoin CAPSULE;ORAL 202099 ANDA Dr. Reddy's Laboratories Limited 55111-113 N 55111-113-81
ZENATANE isotretinoin CAPSULE;ORAL 202099 ANDA Dr. Reddy's Laboratories Limited 55111-113 N 55111-113-78

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Mar 25, 2013TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength20MG
Approval Date:Mar 25, 2013TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength40MG
Approval Date:Mar 25, 2013TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Teva
Harvard Business School
Chubb
Federal Trade Commission
UBS
Colorcon
Cerilliant
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.